(Q33908587)

29 July 2017

1 reference

title

Steroid sex hormones for lower limb atherosclerosis. (English)

1 reference

29 July 2017

Steroid sex hormones for lower limb atherosclerosis (English)

0 references

1 reference

J F Price

1

1 reference

29 July 2017

G C Leng

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2002

0 references

published in

1 reference

29 July 2017

CD000188

1 reference

29 July 2017

2

1 reference

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

29 July 2017

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Sex hormones and coronary disease: a review of the clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

MEASUREMENT OF BLOOD-FLOW THROUGH SKELETAL MUSCLE BY INTRAMUSCULAR INJECTION OF XENON-133

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Testosterone therapy in obliterating arterial lesions in the lower limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Relationship between sex hormones and haemostatic factors in healthy middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Increase of blood fibrinolytic activity by testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Oestrogen and women's heart disease: ESPRIT-UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000188

10.1002/14651858.CD000188

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference